New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 30, 2014
12:27 EDTRT, REGN, TWTR, DEST, NQ, HUM, GNWOn The Fly: Midday Wrap
Stocks on Wall Street were mixed at midday, with the Nasdaq leading and the Dow lagging, after a much better than expected reading on second quarter economic growth in the U.S. and ahead of a statement from the Federal Reserve following its latest policy meeting. With a solid earnings season and the economic data showing growth, investors are now on Fed watch, with the move in the averages potentially illustrating fear that the central bank may begin to get more hawkish. ECONOMIC EVENTS: In the U.S., the Commerce Department estimated that Gross Domestic Product grew at a seasonally adjusted annual rate of 4.0% in the second quarter, easily beating expectations for a growth rate of 3.0%. Payroll company ADP reported private payrolls climbed 218K in July, which was a bit below the 238K forecast. The Federal Reserve wraps up its two-day Federal Open Market Committee meeting today and the accompanying rate decision and statement is scheduled to be released at 2:00 pm ET. COMPANY NEWS: Shares of Twitter (TWTR) surged 20% higher after the social network operator's second quarter results beat analysts' consensus estimates and it raised its fiscal year 2014 revenue and adjusted EBITDA forecasts. Following last night's report, Bank of America Merrill Lynch upgraded Twitter to Buy from Neutral, while the stock was also upgraded to Outperform from Sector Perform at FBN Securities, to Neutral from Sell at UBS and to Market Perform from Underperform at Cowen. MAJOR MOVERS: Among the notable gainers was NQ Mobile (NQ), which jumped 15% to trade near $8 per share after the company reported it has received a non-binding proposal from Bison Capital to acquire all of NQ's outstanding American depositary shares for $9.80 each. Also higher was Regeneron (REGN), which rose 6% after the company announced that nine new Phase 3 Odyssey trials of alirocumab in people with hypercholesterolemia met their primary efficacy endpoint. Among the noteworthy losers was Genworth Financial (GNW), which dropped 13% and was downgraded to Neutral from Outperform at Macquarie after its second quarter earnings report. Also lower following their earnings reports were Humana (HUM), which slid 5%, Ruby Tuesday (RT), which fell over 16%, and Destination Maternity (DEST), which dropped more than 19%. INDEXES: Near midday, the Dow was down 57.70, or 0.34%, to 16,854.41, the Nasdaq was up 9.01, or 0.2%, to 4,451.71, and the S&P 500 was down 3.87, or 0.2%, to 1,966.08.
News For TWTR;GNW;NQ;REGN;HUM;DEST;RT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
January 27, 2015
07:27 EDTTWTRTwitter Q4 results should beat expectations, says Pacific Crest
Subscribe for More Information
January 26, 2015
16:01 EDTTWTROptions Update; January 26, 2015
iPath S&P 500 VIX Short-Term Futures down 1.47 to 30.63. Option volume leaders: AAPL TSLA TWTR AMZN FB NFLX X MSFT BP GILD according to Track Data.
14:07 EDTTWTRTwitter volatility increases into Q4 and outlook
Subscribe for More Information
12:39 EDTHUMHHS Secretary orders Medicare to change payment method, WSJ says
Subscribe for More Information
05:14 EDTREGNRegeneron, Sanofi announce BLA for Praluent accepted for priority review by FDA
Regeneron Pharmaceuticals (REGN) and Sanofi (SNY) announced that the FDA has accepted for priority review the Biologics License Application, or BLA, for Praluent, alirocumab. Under the Prescription Drug User Fee Act, or PDUFA, the goal for a priority review is six months, for a target action date of July 24. Alirocumab is an investigational monoclonal antibody targeting PCSK9 that is intended for the treatment of patients with hypercholesterolemia. The BLA for Praluent contains data from more than 5,000 patients, including 10 Phase 3 ODYSSEY trials. Together with additional ongoing studies including ODYSSEY OUTCOMES, the ODYSSEY clinical trial program will include more than 23,500 patients at more than 2,000 study centers in double-blind, randomized, placebo-and active-controlled trials ranging from 24 weeks to approximately 5 years. Earlier this month, the companies announced that the European Medicines Agency accepted for review the Marketing Authorization Application for Praluent in the European Union. The EMA and FDA have conditionally accepted Praluent as the trade name for alirocumab. The safety and efficacy of alirocumab have not been fully evaluated by any regulatory authority.
January 25, 2015
20:32 EDTTWTRTwitter still has problems, Barron's says
Subscribe for More Information
January 23, 2015
16:01 EDTTWTROptions Update; January 23, 2015
iPath S&P 500 VIX Short-Term Futures up 80c to 32.10. Option volume leaders: AAPL TSLA TWTR AMZN FB FXCM X GDP PBR according to Track Data.
07:39 EDTREGNRegeneron announces EYLEA Injection recommended for approval in EU
Subscribe for More Information
January 22, 2015
16:00 EDTTWTROptions Update; January 22, 2015
iPath S&P 500 VIX Short-Term Futures down 2.13 to 31.32 Option volume leaders: AAPL TSLA TWTR AMZN FB FXCM AVP BAC according to Track Data.
14:26 EDTTWTRTwitter introduces Tweet translation with Bing Translator
Twitter (TWTR) announced that the company has partnered with Bing Translator (MSFT) to provide machine translations of Tweets between more than 40 language pairs. Tweet translation is available on twitter.com, Twitter for iOS, Twitter for Android, and TweetDeck, according to the company's support page about the new feature. Reference Link
13:11 EDTTWTRTwitter higher in volatile trading, levels to watch
Subscribe for More Information
10:39 EDTTWTRTwitter active call volume attributed to takeover speculation
Subscribe for More Information
10:29 EDTTWTRRumor: Twitter strength attributed to takeover speculation
Subscribe for More Information
06:15 EDTTWTRTwitter rolls out 'while you were away' feature
Twitter announced on its blog that it is rolling out a "while you were away feature," or "a recap of some of the top Tweets you might have missed from accounts you follow... Our goal is to help you keep up – or catch up – with your world, no matter how much time you spend on Twitter. With a few improvements to the home timeline we think we can do a better job of delivering on that promise without compromising the real time nature of Twitter. Recaps, marked with a 'While you were away' heading, will begin to appear for all Twitter for iOS users today, and on our Android app and twitter.com soon." Reference Link
05:57 EDTGNWGenworth implied volatility of 72 at upper end of index mean range
January 21, 2015
16:00 EDTTWTROptions Update; January 21, 2015
iPath S&P 500 VIX Short-Term Futures down 1.63 to 33.49. Option volume leaders: AAPL TSLA TWTR AMZN FB RIG C ABX SIRI NFLX according to Track Data.
10:16 EDTREGNLeerink biopharma analysts hold an analyst/industry conference call
Analyst Fernandez, along with Dr. Paul Gurbel and Dr. Richard Becker, discuss AstraZeneca's PEGASUS trial and the current use of Brilinta and dual antiplatelet therapy for prevention of CV disease and implications of the recently completed DAPT trial on an Analyst/Industry conference call to be held on January 21 at 1:30 pm.
January 20, 2015
16:00 EDTTWTROptions Update; January 20, 2015
iPath S&P 500 VIX Short-Term Futures down 36c to 35.12 Option volume leaders: AAPL TSLA TWTR GILD NFLX MGM ABX AMAT JNJ C according to Track Data.
15:24 EDTTWTREarnings Preview: IBM estimates cut by Jefferies, BofA ahead of report
Subscribe for More Information
05:57 EDTTWTRTwitter acquires ZipDial, terms not disclosed
Twitter said in a blog entry that the company has agreed to acquire ZipDial a product partner based in Bangalore, India, "to make Twitter even more accessible to people around the world. Over the next several years, billions of people will come online for the first time in countries like Brazil, India and Indonesia. For many, their first online experience will be on a mobile device – but the cost of data may prevent them from experiencing the true power of the Internet. Twitter, in partnership with ZipDial, can make great content more accessible to everyone... This acquisition significantly increases our investment in India, one of the countries where we’re seeing great growth, and also brings us a new engineering office in Bangalore." Terms of the deal have not been disclosed.
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use